Featured Research

from universities, journals, and other organizations

Chemical Messenger Controls Bone Growth In Embryos, Study Finds

Date:
April 3, 2002
Source:
Washington University School Of Medicine
Summary:
Scientists at Washington University School of Medicine in St. Louis have for the first time identified a chemical messenger that regulates bone development in the growing embryo. The finding is reported in the April 1 issue of the journal Genes and Development.

St. Louis, April 02, 2002 — Scientists at Washington University School of Medicine in St. Louis have for the first time identified a chemical messenger that regulates bone development in the growing embryo. The finding is reported in the April 1 issue of the journal Genes and Development.

“This signaling molecule puts the brakes on the cartilage growth that determines the length of bones,” says David M. Ornitz, Ph.D., professor of molecular biology and pharmacology, who led the study. First author on the paper was Zhonghao Liu, a graduate student at the School of Medicine.

The messenger, known as fibroblast growth factor 18 (FGF 18), also appears to regulate the hardening, or ossification, of bone. “This suggests that FGF 18 coordinates the process by which bones lengthen with the process by which they harden,” Ornitz says. “That came as a surprise to us.”

He believes the study may lead to a better understanding of congenital and genetic diseases that cause bone malformation, and perhaps of cancer and bone diseases such as osteoporosis. Ornitz and his research team engineered mouse embryos that lacked genes for FGF 18. These embryos showed increased growth activity in the bones. For example, in embryos that lacked FGF 18, the growth regions, or growth plates, of the femur were 37 to 60 percent broader than those in normal mouse embryos.

This and other changes seen in the embryos lacking FGF 18 mimic the condition of embryos that lack a receptor molecule known as fibroblast growth factor (FGF) receptor 3. This led Ornitz and his colleagues to conclude that FGF 18 is the messenger molecule for FGF receptor 3.

Receptors are molecules on the surface of cells that trigger some change in the cell when activated by molecules such as hormones or growth factors. Scientists have known for 10 years that FGF receptors are important for skeletal development. For example, mutations in FGF receptor 3 cause achondroplasia, the most common form of dwarfism in humans. But they did not know which of the 22 known fibroblast growth factors activate the receptors associated with developing bone.

But while embryos that lacked FGF 18 were very similar to embryos that lacked FGF receptor 3, there also was an important difference: The bones of mice lacking FGF 18 didn’t begin to harden as soon as they should have.

“Ossification was delayed by about two days, which is a long time for mouse embryos,” says Ornitz. “That suggests that FGF 18 also influences a second receptor, probably FGF receptor 1 or 2.” Ornitz and his colleagues now are working to identify that second receptor and will soon begin studying how FGF 18 is regulated.

Ornitz’ findings may have future clinical applications. Mutations in FGF receptors have been linked to several bone diseases. Mutations in FGF receptor 3, for example, cause several kinds of dwarfism, and mutations in FGF receptors 1 and 2 cause craniosynostosis syndromes, in which the cranial bones fuse prematurely causing deformities of the skull.

“If we understand the relationship between FGF 18 and its receptors,” says Ornitz, “perhaps someday we can prevent some of the pathology that occurs in diseases such as achondroplasia and craniosynostosis syndromes.”

###

Reference:

Liu Z, Xu J, Colvin JS, Ornitz DM. Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18. Genes and Development, 16 (7), 859-869, April 1, 2002.

This research was supported by grants from the National Institute of Child Health and Human Development, the American Heart Association and Zymogenetics Inc.


Story Source:

The above story is based on materials provided by Washington University School Of Medicine. Note: Materials may be edited for content and length.


Cite This Page:

Washington University School Of Medicine. "Chemical Messenger Controls Bone Growth In Embryos, Study Finds." ScienceDaily. ScienceDaily, 3 April 2002. <www.sciencedaily.com/releases/2002/04/020403024959.htm>.
Washington University School Of Medicine. (2002, April 3). Chemical Messenger Controls Bone Growth In Embryos, Study Finds. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2002/04/020403024959.htm
Washington University School Of Medicine. "Chemical Messenger Controls Bone Growth In Embryos, Study Finds." ScienceDaily. www.sciencedaily.com/releases/2002/04/020403024959.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins